Parvez Mohammad Khalid
Department of Pharmacognosy, King Saud University College of Pharmacy, Riyadh 11451, Saudi Arabia.
Future Microbiol. 2017 Aug;12:915-924. doi: 10.2217/fmb-2017-0016. Epub 2017 Jul 7.
Hepatitis E virus (HEV) is a globally important pathogen of acute and chronic hepatitis in humans. The HEV ORF1 gene encodes a nonstructural polyprotein, essential for RNA replication and virus infectivity. Expression and processing of ORF1 polyprotein are shown in prokaryotic and eukaryotic systems, however, its proteolysis into individual proteins is still debated. While molecular or biochemical characterization of methyltransferase, protease, hypervariable region, helicase and RNA polymerase domains in ORF1 has been achieved, the role of the X and Y domains in the HEV life cycle has only been demonstrated very recently. Clinically, detection of a number of ORF1 mutants in infected patients is implicated in disease severity, mortality and drug nonresponse. Moreover, several artificial lethal mutations in ORF1 offer a potential basis for developing live-attenuated vaccines for HEV. This article intends to present the molecular and clinical updates on the HEV ORF1 polyprotein.
戊型肝炎病毒(HEV)是一种在全球范围内引起人类急慢性肝炎的重要病原体。HEV的开放阅读框1(ORF1)基因编码一种非结构多聚蛋白,对RNA复制和病毒感染性至关重要。ORF1多聚蛋白的表达和加工已在原核和真核系统中得到展示,然而,其蛋白水解成单个蛋白质的过程仍存在争议。虽然已对ORF1中的甲基转移酶、蛋白酶、高变区、解旋酶和RNA聚合酶结构域进行了分子或生化特征分析,但直到最近才证实了X和Y结构域在HEV生命周期中的作用。临床上,在感染患者中检测到多种ORF1突变与疾病严重程度、死亡率和药物无反应性有关。此外,ORF1中的几种人工致死突变是开发戊型肝炎减毒活疫苗的潜在基础。本文旨在介绍关于HEV ORF1多聚蛋白的分子和临床最新进展。